# Study to Compare Selective Internal Radiation Therapy (SIRT) Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma (HCC)

> **NCT01135056** · PHASE3 · UNKNOWN · sponsor: **Singapore General Hospital** · enrollment: 360 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DEVICE:** SIR-Spheres
- **DRUG:** Sorafenib tosylate

## Key facts

- **NCT ID:** NCT01135056
- **Lead sponsor:** Singapore General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-07
- **Primary completion:** 2018-07-31
- **Final completion:** 2018-07-31
- **Target enrollment:** 360 (ACTUAL)
- **Last updated:** 2018-04-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01135056

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01135056, "Study to Compare Selective Internal Radiation Therapy (SIRT) Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma (HCC)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01135056. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*